Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketing Authorization from UKMHRA for the below mentioned products:

1) Fluoxetine 10mg Capsules

2) Fluoxetine 30mg Capsules

3) Fluoxetine 60mg Capsules